Sio Capital Management, LLC Curis Inc Transaction History

Sio Capital Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.71 - $2.43 $1.36 Million - $4.65 Million	-1,915,460 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.31 - $5.13 $4.51 Million - $10 Million	-1,951,185 Reduced 50.46%	1,915,460 $4.56 Million
Q4 2021 Feb 14, 2022	BUY	$4.45 - $8.09 $4.24 Million - $7.71 Million	952,518 Added 32.69%	3,866,645 $18.4 Million
Q3 2021 Nov 15, 2021	SELL	$6.94 - $8.85 $3.12 Million - $3.98 Million	-450,278 Reduced 13.38%	2,914,127 $22.8 Million
Q2 2021 Aug 16, 2021	SELL	$7.45 - $16.27 $7.58 Million - $16.6 Million	-1,017,263 Reduced 23.22%	3,364,405 $27.2 Million
Q1 2021 May 14, 2021	SELL	$8.78 - $12.8 $3.29 Million - $4.8 Million	-374,770 Reduced 7.88%	4,381,668 $49.6 Million
Q4 2020 Feb 16, 2021	SELL	$1.08 - $8.2 $209,102 - $1.59 Million	-193,613 Reduced 3.91%	4,756,438 $39 Million
Q3 2020 Nov 16, 2020	BUY	$0.95 - $1.42 $617,500 - $923,000	650,000 Added 15.12%	4,950,051 $5.79 Million
Q2 2020 Aug 14, 2020	BUY	$0.63 - $1.7 $2.71 Million - $7.31 Million	4,300,051 New	4,300,051 $5.2 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sio Capital Management, LLC with notifications on news.